ABSTRACT
The choice of technology of electrophoretic fractionating of blood serum proteins is determined, besides the analytical characteristics, by its economic component. The electrophoresis technologies developed by the R&D production facility "Astra" (Russia) and the firm "PZ Cormay S.A." (Poland) are compared from a viewpoint of applicability in routine laboratory, practice and diagnostics of multiple plasma cell myeloma in particular. It is established that under the comparable economic, "consumer" and analytic characteristics of technologies in the diagnostic process the application of the technology in agarose gel ("PZ Cormay S.A.") is more preferable.
Subject(s)
Electrophoresis, Agar Gel/methods , Electrophoresis, Cellulose Acetate/methods , Blood Proteins , Electrophoresis, Agar Gel/economics , Electrophoresis, Agar Gel/instrumentation , Electrophoresis, Cellulose Acetate/economics , Electrophoresis, Cellulose Acetate/instrumentation , Humans , Multiple Myeloma/diagnosisABSTRACT
The exorbidant cost of electrophoretic analysis, many a times becomes the major limitation factor. As most of the clinical laboratories import the cellulose acetate membrane which costs 5 to 6 U.S. $ that is Rs. 180/- to Rs. 210/-, the final cost goes upto Rs. 350/- to Rs. 500/-. We have observed that CAN strips can be effectively reused 6 to 7 times for subsequent electrophoretic analysis.
